Objectives: For the patients with T2a N0 non-small cell lung cancer (NSCLC), the extent of lymph node removal required for survival is controversial. We purposed to clarify the correlation between the number of lymph nodes (LNs) examined and survival for those patients. Methods: We reviewed 549 patients pathologically confirmed as T2a stage and lymph node negative. According to Martingale residuals of the Cox model, the patients were classified into 4 groups by the number of examined LNs (1-2 LNs, 3-7 LNs, 8-11 LNs, and ≥12 LNs). Kaplan-Meier analysis and Cox regression analyses were used to evaluate the association between survival and the number of examined LNs. Results: The five-year cancer-specific survival rate was 59.8% for patients with one to two negative LNs, compared with 67.4%, 69.7% and 77.6% for those with three to seven, eight to 11 and more than 11 LNs examined, respectively (P = 0.025). There was a significant drop in mortality risk in patients with more LNs examined. The lowest mortality risk occurred in those patients with 32 or more LNs examined. Multivariate analysis showed that age and the number of examined LNs were strong independent predictors of survival. Conclusion: The number of examined LNs is a strong independent prognostic factor. Our study demonstrated that NSCLC patients with T2a N0 should have at least 12 LNs examined. The result might be considered as a reference for the optimal number of resected LNs in surgical strategy for NSCLC patients in T2aN0. Disclosure: No significant relationships.
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